Immunome
IMNM
$13.83
Share price
-3.96%
Change (1 day)
143.92%
Change (1 year)
Categories
Immunome (IMNM) - P/B ratio
P/B ratio as of May 2024 : 7.20
According to Immunome's latest financial reports the company has a price-to-book ratio of 7.20.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Immunome - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.81 | 136.94% |
| 2022-12-31 | 1.61 | -50.54% |
| 2021-12-31 | 3.25 | 31.87% |
| 2020-12-31 | 2.47 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -62.32% | 🇺🇸 USA |